Saturday, April 19, 2014
It should be called Crucifixation Friday; Death by Torture Friday; Travesty Show Trials Friday; Grand Miscarriage of Justice Friday.
The Good News is, He's overcome the world, and our sin. Very good news indeed. Therefore, even amidst the horror, it is Good Friday.
Speaking of horror, the movie The Passion of the Christ is available free & full length on You Tube. Among true believers, the almost universal reaction to watching it, is, a deep need, a motivated imperative, to serve one another. The kind of change that happens from the inside out.
"We are Sunday morning people, living in a Friday world", someone said. Lately, I have been living in the Friday world. It is dark.
It was very dark for those first believers, all scattered, all hiding, all betrayed Him, all saw Him nailed, and watched Him die. They had followed Him for years. Literally years. Given up everything. And now, everything He had said . . . dead. They SAW Him DIE; dead, Dead, DEAD. And with Him died their hopes and dreams. Jesus, Dead. What they had been so sure they believed, Dead. His promises to them, they perceived to be Dead. Their personal honor DEAD when they denied Him; dead, Dead, DEAD.
Horrific. In so many ways. So dark. What a horrible, horrible, terrible day.
When you are living in a dark Friday, remember that Sunday morning is coming. Not soon enough for most of us. But it WILL come. The promises ARE true. Remember that on the road to Emaus, everything will be made clear and explained, and you will reaffirm what was true all along - that God is GOOD, ALL of the time. He's alive forevermore, and we CAN be of good cheer, because He HAS overcome the world.
What is it that is dead, Dead, DEAD in your life? Or on life support? Are you on the verge of giving up? Have you already given up? Do you feel betrayed?
Dr. Dobson wrote about the betrayal factor:
It's an immensely practical book for those who are struggling with trials and heartaches they can’t understand. Why does disease, natural disaster, divorce, rejection, death, or some other sorrow seep into our lives when we are trying to serve the Lord? This book deals unflinchingly with life’s most troubling question—“Why?” Drawing on his long experience as a Christian psychologist and family counselor, Dr. Dobson brings hope to those who have almost given up. When God Doesn’t Make Sense also helps believers avoid the “betrayal barrier”—the sense that God is abandoning them amid the storms of life.
During your dark day(s), how did you deny Him or the faith? Remind yourself, and remind your circumstances, that SUNDAY MORNING IS COMING. No matter what your circumstances say now, no matter what dark truth you are walking in, no matter how deep the shadows in the valley of death are, no matter how dead or betrayed or despairing you feel, remember that on the road to Emaus, every unexplainable, mystifying, discordant, contradicting circumstance will be made clear and explained, and you will reaffirm and understand then what was true all along - that God is GOOD, ALL of the time.
Until then, trust Him for Sunday morning.
I don't know the Why - but there are two bedrock things that I DO know.
The first is that Sunday morning is definitely coming, and NOTHING can stop it from arriving. It's COMING. Get ready.
And the second bedrock thing I know that I know that I know, and that I can hang on to, is that when Sunday morning does arrive, ALL THINGS WILL BE MADE NEW, including what was dead in my life. It will ALL be redeemed, restored, renewed, transformed.
And if we still don't understand at that point, are still storm tossed and beaten down and confused and in mourning, Jesus will personally explain it as our Great High Priest; He will take time out of His day to personally walk with us on the road of life and make it clear. It will still be strange, wonderful, terrible, incredible and unthinkable; but He will gently finish it with us and give us peace, and produce joy in our lives where there was only deadness before.
Today it is a very dark Friday. But TRUST HIM FOR SUNDAY MORNING. In the future when we look back to today, we will be able to say, truly, this was Good Friday!
"Do not give in to despair. We are the Easter people, and hallelujah is our song!"
Thursday, April 17, 2014
The Thursday before Easter is called Maundy Thursday, when we remember the Last Passover Supper, the bread and the wine of the New Covenant, and foot washing.
Much indeed, to be thankful for.
Leonardo DaVinci's Last Supper
It was time for supper, . . . so Jesus got up from the table, took off his robe, wrapped a towel around his waist, and poured water into a basin. Then he began to wash the disciples’ feet, drying them with the towel he had around him.
When Jesus came to Simon Peter, Peter said to him, “Lord, are you going to wash my feet?”
Jesus replied, “You don’t understand now what I am doing, but someday you will.”
After washing their feet, he put on his robe again and sat down and asked, “Do you understand what I was doing?
You call me ‘Teacher’ and ‘Lord,’ and you are right, because that’s what I am. And since I, your Lord and Teacher, have washed your feet, you ought to wash each other’s feet. I have given you an example to follow. Do as I have done to you. I tell you the truth, slaves are not greater than their master. Nor is the messenger more important than the one who sends the message. Now that you know these things, God will bless you for doing them.
While they were eating, Jesus took bread, and when he had given thanks, he broke it and gave it to his disciples, saying, “This is My body, which is given for you; do this in remembrance of Me.”
In the same way He took the cup also after supper, saying, “This cup is the new covenant in My blood, which is poured out and shed for you; do this, as often as you drink it, in remembrance of Me.”
And they all drank from it.
We remember, Lord Jesus. We remember.
Sunday, April 13, 2014
Many Rabbis could not understand, nor reconcile at all!, the many prophets of old who foretold what almost seemed like two different Messiahs; one prophesied meekly arriving on a foal of donkey worshipped by the lowly masses, rejected by the religious rulers and nobles.
And the same Messiah (??) arriving on a steed, worshipped by all the kings of the earth as the King of All. How could this be?
Completed Jews & redeemed Gentiles have the answer: He DID come meekly, riding on the foal of donkey as told in Matthew, celebrated by the masses and rejected by the nobles and ruling classes.
And He IS coming again as the Reigning King of Kings & Lord of Lords, in Revelation, when all knees will bow to Him including the nobles and ruling classes.
But today we celebrate Palm Sunday, His first triumphal entry into Jerusalem as told by the prophets of old, as we look forward to the promise of New Jerusalem, also as told by the prophets of old.
Saturday, April 12, 2014
More reasons to take turmeric, in addition to cancer, inflammation, alzheimers, diabetes, etc.
The Spice That Prevents Fluoride From Destroying Your Brain
By Sayer Ji
Friday, April 11, 2014
Since many online articles later have their content edited, rewritten, made (even more) politically correct, or removed (read: journalism morally bankrupt), I am posting the article here as it was when I found it online.
Researchers Raise Questions About Flu Drugs
Michelle Healy, USA TODAY 2:24 p.m. EDT April 10, 2014
The antiviral medications Tamiflu and Relenza are commonly used to prevent and treat influenza, but a new review is questioning their effectiveness.
International investigators question whether popular antiviral drugs Tamiflu and Relenza can actually stop the flu. The drugs have been stockpiled by dozens of governments worldwide in case of a global flu outbreak and was widely used during the 2009 swine flu pandemic.
A new review is questioning the effectiveness of two key drugs enlisted in the fight against influenza.
The antiviral drugs Tamiflu (oseltamivir) and Relenza (zanamivir ) are commonly used to treat influenza in healthy adults and children.
In the case of Tamiflu, the drug does shorten symptoms of influenza by about half a day — as the manufacturer suggests — but there is insufficient evidence to support claims that it reduces hospital admissions or serious complications, such as confirmed pneumonia or bronchitis, says the review published today by The Cochrane Collaboration, a non-profit, international health-care research network, and the British medical journal BMJ.
The review also cites evidence from treatment trials (when the drug was given for about five days) that Tamiflu increased the risk of nausea and vomiting in adults by around 4% and in children by around 5%.
And evidence from prophylaxis or prevention trials (when the drug was given for about six weeks) showed Tamiflu use was related to increased risks of headaches, psychiatric disturbances, especially depression and confusion, and renal problems.
The review of studies related to the nasal spray Relenza found fewer adverse effects compared with Tamiflu, but also showed no effectiveness against flu complications or reducing hospitalizations.
Although Relenza, likewise reduced symptoms by about half a day, the reviewers report "that it may be no better than other symptom relief medications," such as drinking clear liquids, gargling with warm salt water, and using saline nasal drops, over-the-counter decongestants, and pain relievers such as acetaminophen and ibuprofen.
In a statement, Relenza-maker GlaxoSmithKline says, "We continue to believe the data from Relenza's clinical trial (program) support its effectiveness against flu and that when used appropriately, in the right patient, it can reduce duration of flu symptoms."
Tamiflu-maker Genentech, a division of Roche, also challenged the review's conclusions, noting that the researchers focused on only 20 out of 77 clinical trials, "all made available to them," and excluded "real-world data" from non-Roche-sponsored observational trials.
In some cases, the reviewers also failed to analyze the appropriate statistical information, which "doesn't give you an accurate representation of what the true effect of the medicine is," says Barry Clinch, principal clinical scientist with Roche.
Peter Doshi, an assistant professor of pharmaceutical health services research at the University of Maryland School of Pharmacy and a co-author of the Cochrane review, says the team focused on the 20 trials because it was more interested in the more rigorous randomized, placebo-controlled research. "Many of these 77 trials did not meet that criteria," he says.
"I'm not interested in health scares," Doshi adds. "What we've found here are statistically significant increases. Do I know absolutely for certain, without a shadow of a doubt, that Tamiflu is responsible for these (negative effects), based on the trial methodology? No. But what I'm seeing here are clear reasons to be concerned and to look into it further."
Claims about the effectiveness of the antiviral drugs were a key factor in decisions made by governments around the world to stockpile the drugs in case of a global flu outbreak and was widely used during the 2009 H1N1/swine flu pandemic, says Fiona Godlee, editor-in-chief, BMJ.
Since that pandemic, Cochrane investigators, commissioned by the United Kingdom government, have attempted "to get to a sound evidence base as to whether this drug was effective and safe," says Godlee.
The new report cites a U.S. Government Accounting Office (GAO) document stating that the U.S. has spent more than $1.3 billion buying a strategic reserve of antivirals. The British government has spent almost £424 million or $710,030,400 for a stockpile of about 40 million doses, according to documents.
Unlike the case in many countries, FDA-approved labeling for Tamiflu says that the drug "has not been shown" to prevent serious bacterial complications like those associated with pneumonia and other upper respiratory infections, a fact that "contradicts the assumptions that were made when stockpiling occurred," Doshi says.
In 2012, after reviewing an earlier Cochrane review that raised similar questions about the value of the antiviral medications for the prevention and treatment of influenza, the Centers for Disease Control and Prevention did not change its recommendation on the use of the antiviral drugs, calling them "an important adjunct in the prevention and treatment of influenza."
CDC's response this week was similar. "We carefully review all available data including randomized controlled trials and observational studies when making recommendations. There is a substantial and growing number of observational studies that show the clinical benefit of antiviral treatment of seasonal and pandemic influenza.
Carol's note: google Tamiflu scandal
Get An Email Alert Each Time CAROLFAITHWALKR Posts